Patients undergoing hemodialysis in the United States have high rates of mortality and morbidity. This, in part, is probably due to the delivery of insufficient amounts of dialysis treatment. The determination of an adequate quantity of therapy (Kt/V = 1.0) was generated from data of the National Cooperative Dialysis Study (NCDS). The technology and subjects studied at the time of the NCDS do not adequately reflect current conditions. Hemodialysis can now be performed more efficiently, anemia can be corrected, and there is an availability of high-flux/biocompatible dialyzers. Patients are now older, and there is a high proportion of diabetic patients. The optimal hemodialysis treatment for the current population or patients is unknown.
The aim of this proposal is to carry out a cooperative multi-center clinical trial, Mortality and Morbidity in Hemodialysis (MMHD), with the goal of determining the effects of dialysis intensity and dialyzer type on mortality (primary outcome) and morbidity (secondary outcome). Fifteen centers will each enroll and maintain 60 patients in the study. Their demographic and clinical status should reflect those of the general dialysis population. They will be randomized into four treatment groups to address the following specific aims: to determine if maintaining a Kt/V of 1.4 (range 1.3-1.5) confers lower rates of mortality and morbidity compared to a Kt/V of 1.0 (range 0.9-1.1) in hemodialysis patients; to evaluate whether the use of high- flux/biocompatible dialyzers is associated with less mortality and morbidity than cuprophane dialyzers; and to assess if the more aggressive interventions are safe and acceptable to patients. This large study will require high quality data collection and uniform standards of care among all participating dialysis centers. If these specific aims are fulfilled a more rational and effective strategy to optimally treat hemodialysis patients will be devised and implemented.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01DK049240-05
Application #
2770488
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Kusek, John W
Project Start
1994-09-30
Project End
2001-08-31
Budget Start
1998-09-18
Budget End
1999-08-31
Support Year
5
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Washington University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Unruh, Mark L; Newman, Anne B; Larive, Brett et al. (2008) The influence of age on changes in health-related quality of life over three years in a cohort undergoing hemodialysis. J Am Geriatr Soc 56:1608-17
Delmez, James A; Yan, Guofen; Bailey, James et al. (2006) Cerebrovascular disease in maintenance hemodialysis patients: results of the HEMO Study. Am J Kidney Dis 47:131-8
Unruh, Mark; Miskulin, Dana; Yan, Guofen et al. (2004) Racial differences in health-related quality of life among hemodialysis patients. Kidney Int 65:1482-91
Unruh, Mark; Yan, Guofen; Radeva, Milena et al. (2003) Bias in assessment of health-related quality of life in a hemodialysis population: a comparison of self-administered and interviewer-administered surveys in the HEMO study. J Am Soc Nephrol 14:2132-41
Miskulin, D C; Athienites, N V; Yan, G et al. (2001) Comorbidity assessment using the Index of Coexistent Diseases in a multicenter clinical trial. Kidney Int 60:1498-510
Delmez, J A; Kelber, J; Norword, K Y et al. (1996) Magnesium carbonate as a phosphorus binder: a prospective, controlled, crossover study. Kidney Int 49:163-7
Delmez, J A (1996) The spectrum of renal osteodystrophy in peritoneal dialysis patients. Perit Dial Int 16:24-5